There are multiple links in the WP article to the original studies.
Statins
Intensive Tx Fails to Slow Atherosclerosis | Medpage Today
“When we see something that surprises us and flies in the face of what is understood, it requires another look — maybe a different cohort, larger numbers, longer follow-up,”
via Intensive Tx Fails to Slow Atherosclerosis | Medpage Today.
Surprised? As long as we continue to focus on pharmaceuticals as the answer, no one should be surprised.
WOSCOPS at 20 Years Shows ‘Lifetime’ Benefit of Statins
Statins: The Good, the Bad, and the Unknown
ASCVD Risk Estimator
More Docs Wonder If Statins Are Worth the Risks
Drug Safety Labeling Changes – February 2014
Safety Information > February 2014.
Get to Know an Enzyme: CYP3A4.
I routinely check the FDA drug safety information for personal reasons. One thing led to another, thus the reason for the CYP3A4 link. If you like puzzles, try to figure out why I’m reading up on CYP3A4. My son the molecular biochemist soon to be MD would have no problem figuring this out.
Large Study Affirms Safety of Statins
The study included information from 135 randomized trials — 55 with a placebo control and 80 with an active comparator — that included a total of 246,955 participants with or without cardiovascular disease. The study initially included trials of atorvastatin, fluvastatin, simvastatin, lovastatin, pravastatin, and rosuvastatin (Crestor); trials of pitavastatin (Livalo) were added post hoc because the protocol was already being finalized at the time the drug was approved.
Risk of DM Among Patients Treated with Statins – BMJ
Conclusions – Compared with pravastatin, treatment with higher potency statins, especially atorvastatin and simvastatin, might be associated with an increased risk of new onset diabetes.
via Risk of incident diabetes among patients treated with statins: population based study | BMJ.
Researchers Suggest 2 Paths to get Patients Back on Statins
…statin discontinuation is common and has been linked to a greater risk of heart-related events and death in patients who have coronary artery disease, the study said.
via Researchers suggest 2 paths to get patients back on statins – amednews.com.
One out of every four Americans over the age of 45 are on a statin.
lifeunderwriter.net 
You must be logged in to post a comment.